Commission Delegated Regulation (EU) 2024/1401 of 7 March 2024 amending Delegated Regulation (EU) 2022/2104 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council as regards marketing standards for olive oil

• CELEX: Delegated Regulation (EU) 2024/1401
• Articles: 4

Article 1

Delegated Regulation (EU) 2022/2104 is amended as follows:

(1)

Annex I is amended as follows:

(a)

table B is replaced by the table set out in Annex I to this Regulation;

(b)

its Appendix is deleted;

(2)

Annex III is replaced by the text set out in Annex II to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX I

ANNEX I

‘B.    Purity characteristics

Category

Fatty acid composition

( 1 )

Total transoleic isomers

(%)

Total trans- linoleic + trans-linolenic isomers

(%)

Stigmasta- dienes

(mg/kg)

( 2 )

ΔΕCN42

2-glyceryl monopalmitate

(%)

Myristic

(%)

Linolenic

(%)

Arachidic

(%)

Eicosenoic

(%)

Behenic

(%)

Lignoceric

(%)

1.

Extra virgin olive oil

≤ 0,03

≤ 1,00  ( 3 )

≤ 0,60

≤ 0,50

≤ 0,20

≤ 0,20

≤ 0,05

≤ 0,05

≤ 0,05

≤ |0,20 |

≤ 0,9 if total palmitic acid % ≤ 14,00 %

≤ 1,0 if total palmitic acid % > 14,00 %

2.

Virgin olive oil

≤ 0,03

≤ 1,00  ( 3 )

≤ 0,60

≤ 0,50

≤ 0,20

≤ 0,20

≤ 0,05

≤ 0,05

≤ 0,05

≤ |0,20 |

≤ 0,9 if total palmitic acid % ≤ 14,00 %

≤ 1,0 if total palmitic acid % > 14,00 %

3.

Lampante olive oil

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,20

≤ 0,20

≤ 0,10

≤ 0,10

≤ 0,50

≤ |0,30 |

≤ 0,9 if total palmitic acid % ≤ 14,00 %

≤ 1,1 if total palmitic acid % > 14,00 %

4.

Refined olive oil

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,20

≤ 0,20

≤ 0,20

≤ 0,30

—

≤ |0,30 |

≤ 0,9 if total palmitic acid % ≤ 14,00 %

≤ 1,1 if total palmitic acid% > 14,00 %

5.

Olive oil composed of refined olive oil and virgin olive oils

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,20

≤ 0,20

≤ 0,20

≤ 0,30

—

≤ |0,30 |

≤ 0,9 if total palmitic acid% ≤ 14,00 %

≤ 1,0 if total palmitic acid% > 14,00 %

6.

Crude olive-pomace oil

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,30

≤ 0,20

≤ 0,20

≤ 0,10

—

≤ |0,60 |

≤ 1,4

7.

Refined olive-pomace oil

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,30

≤ 0,20

≤ 0,40

≤ 0,35

—

≤ |0,50 |

≤ 1,4

8.

Olive-pomace oil

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,30

≤ 0,20

≤ 0,40

≤ 0,35

—

≤ |0,50 |

≤ 1,2

Table B continued

Category

Sterols composition

Total sterols

(mg/kg)

Erythrodiol and uvaol (**) (%)

Waxes (**) (mg/kg)

Chole-sterol (%)

Brassica-sterol (%)

Campe-sterol(%)

Stigmasterol (%)

Apparent β–sito-sterol

( 4 )

(%)

Δ-7-stigma-stenol (%)

1.

Extra virgin olive oil

≤ 0,5

≤ 0,1

≤ 4,0  ( 5 )

< Camp.

≥ 93,0

≤ 0,5  ( 6 )

≥ 1 000

≤ 4,5

C42 + C44 + C46 ≤ 150

2.

Virgin olive oil

≤ 0,5

≤ 0,1

≤ 4,0  ( 5 )

< Camp.

≥ 93,0

≤ 0,5  ( 6 )

≥ 1 000

≤ 4,5

C42 + C44 + C46 ≤ 150

3.

Lampante olive oil

≤ 0,5

≤ 0,1

≤ 4,0

—

≥ 93,0

≤ 0,5  ( 7 )

≥ 1 000

≤ 4,5  ( 8 )

C40 + C42 + C44 + C46 ≤ 300  ( 8 )

4.

Refined olive oil

≤ 0,5

≤ 0,1

≤ 4,0

< Camp.

≥ 93,0

≤ 0,5  ( 9 )

≥ 1 000

≤ 4,5  ( 10 )

C40 + C42 + C44 + C46 ≤ 350

5.

Olive oil composed of refined olive oil and virgin olive oils

≤ 0,5

≤ 0,1

≤ 4,0

< Camp.

≥ 93,0

≤ 0,5  ( 9 )

≥ 1 000

≤ 4,5

C40 + C42 + C44 + C46 ≤ 350

6.

Crude olive-pomace oil

≤ 0,5

≤ 0,2

≤ 4,0

—

≥ 93,0

≤ 0,5  ( 11 )

≥ 2 500

> 4,5  ( 12 )

C40 + C42 + C44 + C46 > 350  ( 12 )

7.

Refined olive-pomace oil

≤ 0,5

≤ 0,2

≤ 4,0

< Camp.

≥ 93,0

≤ 0,5  ( 11 )

≥ 1 800

> 4,5

C40 + C42 + C44 + C46 > 350

8.

Olive-pomace oil

≤ 0,5

≤ 0,2

≤ 4,0

< Camp.

≥ 93,0

≤ 0,5  ( 11 )

≥ 1 600

> 4,5

C40 + C42 + C44 + C46 > 350

Notes:

(a)

The results of the analyses must be expressed to the same number of decimal places as used for each characteristic. The last digit must be increased by one unit if the following digit is greater than 4.

(b)

If just a single characteristic does not match the values stated, the category of an oil shall be changed or the oil shall be declared non-compliant for the purposes of this Regulation.

(c)

For lampante olive oil, both quality characteristics marked with an asterisk (*) may differ simultaneously from the limits established for that category.

(d)

If a characteristic is marked with two asterisks (**), this means that for crude olive-pomace oil, it is possible for both the relevant limits to be different from the stated values at the same time. For olive-pomace oil and refined olive-pomace oil, one of the relevant limits may be different from the stated values.’

( 1 )   Other fatty acids content (%): palmitic: 7,00-20,00; palmitoleic: 0,30-3,50; heptadecanoic: ≤ 0,40; heptadecenoic ≤ 0,60; stearic: 0,50-5,00; oleic: 55,00-85,00; linoleic: 2,50-21,00.

( 2 )   Total isomers which could (or could not) be separated by capillary column.

( 3 )   When the linolenic acid is more than 1,00 but less than or equal 1,40, the ratio apparent β-sitosterol/campesterol has to be greater than or equal to 24.

( 4 )   Apparent β-sitosterol: Δ-5,23-stigmastadienol+clerosterol+ β-sitosterol+sitostanol+ Δ-5-avenasterol+ Δ-5,24-stigmastadienol.

( 5 )   An extra virgin or virgin olive oil that exhibits 4,0 < campesterol % ≤ 4,5 is authentic provided that stigmasterol ≤ 1,4 %, Δ-7-stigmastenol ≤ 0,3 % and all other parameters lie within the limits fixed in this Regulation.

( 6 )   An extra virgin or virgin olive oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔECN42 ≤|0,10| and all other parameters lie within the limits fixed in this Regulation.

( 7 )   A lampante olive oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔΕCN42 ≤ |0,15|, stigmastadienes ≤ 0,30 mg/kg and all other parameters lie within the limits fixed in this Regulation.

( 8 )   Oils with a wax content of between 300 mg/kg and 350 mg/kg are considered to be lampante olive oil if the total aliphatic alcohol content is less than or equal to 350 mg/kg or if the erythrodiol and uvaol content is less than or equal to 3,5 %.

( 9 )   A refined olive oil or olive oil composed of refined olive oil and virgin olive oils that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔΕCN42 ≤ |0,15| and all other parameters lie within the limits fixed in this Regulation.

( 10 )   Oils with an erythrodiol + uvaol content of between 4,5 and 6 % must have an erythrodiol content of less than or equal to 75 mg/kg.

( 11 )   A crude olive-pomace oil or refined olive-pomace oil or olive-pomace oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that stigmasterol ≤ 1,4 %, ΔECN42 ≤ |0,40| and all other parameters lie within the limits fixed in this Regulation.

( 12 )   Oils with a wax content of between 300 mg/kg and 350 mg/kg are considered to be crude olive-pomace oil if the total aliphatic alcohol content is above 350 mg/kg and if the erythrodiol and uvaol content is greater than 3,5 %.

ANNEX II

ANNEX II

‘ANNEX III

CORRELATION TABLE

Implementing Regulation (EU) No 29/2012

Regulation (EEC) No 2568/91

This Regulation

Implementing Regulation (EU) 2022/2105

—

—

Article 1, point (a)

—

—

Article 1

—

—

Article 2(2)

Article 1(1)

Article 1, point (b), and Article 1(2)

Article 1(2)

Article 1, point (b)

Article 2, first paragraph

Article 4(1)

Article 2, second paragraph

Article 4(2)

Article 3, first paragraph

Article 6(1)

Article 3, second paragraph, points (a) to (d)

Article 6(2), points (a) to (d)

Article 4(1), first subparagraph

Article 8(1)

Article 4(1), second subparagraph

Article 8(2)

Article 4(1), third subparagraph

—

Article 4(2)

Article 8(3)

Article 4(3)

Article 8(4)

Article 4(4)

Article 8(5)

Article 4(5), first subparagraph

Article 8(6)

Article 4(5), second subparagraph

Article 8(7)

Article 4a

Article 7

Article 4b

Article 5

Article 5, first paragraph, points (a) to (d)

Article 10, points (a) to (d)

Article 5, first paragraph, point (e)

Article 11(1) and (2)

Article 5, second paragraph

—

Article 5a, first paragraph

Article 11(3)

Article 5a, second paragraph

Article 11(4)

Article 5a, third paragraph

Article 11(5)

Article 6(1), first subparagraph

Article 12(1)

Article 6(1), second subparagraph

Article 12(2)

Article 6(1), third subparagraph

Article 3(3)

Article 6(2), first subparagraph

Article 12(3)

Article 6(2), second subparagraph

Article 12(4)

Article 6(3)

Article 12(5)

—

—

Article 12(6)

Article 6(4)

—

Article 7

Article 5(2)

Article 8(1)

Article 2(3)

Article 8(2)

Article 4(3)

Article 8(3)

Article 4(2)

Article 8(4)

Article 4(3)

Article 8a

Article 2(1) and Article 4(1)

Article 9(1), first subparagraph

Article 13(1)

Article 9(1), second subparagraph

Article 13(2)

Article 9(1), third subparagraph

—

Article 9(1), fourth subparagraph

—

Article 9(1), fifth subparagraph

—

Article 9(2),first subparagraph

Article 6(1)

Article 9(2), second subparagraph, points (a), (b) and (c)

Article 6(2), points (a), (b) and (c)

Article 9(2), third subparagraph

Article 9

—

Article 6(3)

Article 10, first paragraph, introductory sentence

Article 14

Article 10, first paragraph, points (a) to (d), and second paragraph

—

Article 10a

Article 14

Annex I

—

Annex II

—

Article 1(1)

Article 2(1), points (a) and (b)

Article 1(2)

Article 2(1), point (c)

Article 1(3)

Article 2(1), point (d)

Article 1(4)

Article 2(1), point (e)

Article 1(5)

Article 2(1), point (f)

Article 1(6)

Article 2(1), point (g)

Article 1(7)

Article 2(1), point (h)

—

—

Article 2(2)

—

—

Article 3(1) and (2)

Article 2(1)

Article 7

Article 2(1), point (a)

Annex I, point 1

Article 2(1), point (b)

Annex I, point 2

Article 2(1), point (c)

—

Article 2(1), point (d)

—

Article 2(1), point (e)

Annex I, point 3

Article 2(1), point (f)

Annex I, point 4

Article 2(1), point (g)

Annex I, point 6

Article 2(1), point (h)

—

Article 2(1), point (i)

Annex I, point 5

Article 2(1), point (j)

Annex I, point 9

Article 2(1), point (k)

Annex I, point 10

Article 2(1), point (l)

Annex I, point 8

Article 2(1), point (m)

Annex I, point 7

Article 2(2), first subparagraph and part of point 9.4 of Annex XII

Article 10(1)

Article 2(2), second subparagraph

Article 11(1)

Article 2(2), third subparagraph

Article 11(2)

—

Article 11(3)

part of point 9.4 of Annex XII

Article 11(4)

Article 2(3), first subparagraph

Article 3(1)

Article 2(3), second subparagraph

Article 3(2)

Article 2(4), first subparagraph

Article 9(2)

Article 2(4), second subparagraph

Article 9(3)

Article 2(4), third subparagraph

Article 9(4)

Article 2(5)

Article 9(5)

Article 2a(1)

Article 3(1)

Article 2a(2)

Article 3(3)

Article 2a(3)

Article 3(4)

Article 2a(4), first subparagraph

Article 3(5)

Article 2a(4), second subparagraph

Article 3(2)

Article 2a(5)

Article 9(1)

Article 3, first paragraph

Article 13(1)

Article 3, second paragraph

Article 3(6)

Article 4(1), first subparagraph

Article 10(1)

Article 4(1), second subparagraph

Article 10(2)

Article 4(1), third subparagraph

Article 10(3)

Article 4(2)

Article 10(4)

Article 4(3)

-

Article 6(1)

Article 12(1)

Article 6(2)

Article 12(2)

Article 7

—

Article 7a, first subparagraph

Article 5(1)

Article 7a, second paragraph

Article 2(2)

Article 8(1)

—

Article 8(2)

Article 14

Annex I

Annex I

Annex XII, point 3.3

Annex II

Annex Ia, except for point 2.1

Annex II

Annex Ia, point 2.1

Article 9(6)

Annex Ib

Annex III

Annex III

—

Annex IV

—

Annex VII

—

Annex IX

—

Annex X

—

Annex XI

—

Annex XII, except for point 3.3 and part of point 9.4

—

Annex XV

Annex IV

Annex XVI

—

Annex XVII

—

Annex XVIII

—

Annex XIX

—

Annex XX

—

Annex XXI

Annex V

’